Cavanaugh, Kevin2010-07-292010-07-292010-07-29https://hdl.handle.net/11299/92560The information provided in this handout does not necessarily reflect the views of the University of Minnesota Medical School physicians and faculty. These materials are provided for informational purposes only and are in no way intended to take the place of the advice and recommendations of your personal health care provider. You use the information provided in these handouts at your own risk.The use of prophylactic quadrivalent HPV vaccine in women aged 24-45 is safe and effective against infection with HPV serotypes 6, 11, 16, and 18, and likely confers protection against cervical, vulvar, and vaginal intraepithelial neoplasia and external genital disease.en-USHPVGardasilPap smearOther